Old Web
English
Sign In
Acemap
>
authorDetail
>
Bolanle K. Akinlade
Bolanle K. Akinlade
Medicine
Cefdinir
Diabetes mellitus
Internal medicine
Adverse effect
4
Papers
89
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Molecular Characterization of Staphylococcus aureus Isolates from a 2005 Clinical Trial of Uncomplicated Skin and Skin Structure Infections
2007
Antimicrobial Agents and Chemotherapy
Ronald N. Jones
Angela M. Nilius
Bolanle K. Akinlade
Lalitagauri M. Deshpande
Gerard F. Notario
Show All
Source
Cite
Save
Citations (21)
Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
2006
Current Medical Research and Opinion
Philip Giordano
Dirk M. Elston
Bolanle K. Akinlade
Kurt Weber
Gerard F. Notario
Todd A. Busman
Mary Cifaldi
Angela M. Nilius
Show All
Source
Cite
Save
Citations (36)
Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children
2006
Current Medical Research and Opinion
Stan L. Block
Jordana K. Schmier
Gerard F. Notario
Bolanle K. Akinlade
Todd A. Busman
George E. MacKinnon
Michael T. Halpern
Angela M. Nilius
Show All
Source
Cite
Save
Citations (23)
Aspirin, clopidogrel, or both for secondary prevention of coronary disease [3] (multiple letters)
2003
The New England Journal of Medicine
Bolanle K. Akinlade
James A. de Lemos
Darren K. McGuire
Eamon C. Armstrong
Scott D. Ramsey
Robert J. Yaes
Jean Michel Gaspoz
Pamela G. Coxson
Lee Goldman
Alastair J. J. Wood
Show All
Source
Cite
Save
Citations (9)
1